BioVexLab Solutions

BioVexLab Solutions is a biotechnology company dedicated to advancing the science and applications of extracellular vesicles (EVs). We specialize in the isolation, purification, characterization, and functional evaluation of extracellular vesicles derived from human, bacterial, and plant sources.

Our mission is to bridge cutting-edge EV science with real-world biomedical and biotechnological applications. By combining scientific expertise, advanced analytical technologies, and a rigorous approach to quality and reproducibility, we help researchers and innovators generate reliable data, accelerate discovery, and translate emerging EV technologies into meaningful applications.

From fundamental research and biomarker discovery to drug delivery, therapeutic development, and next-generation biotechnology, BioVexLab Solutions provides specialized expertise and tailored solutions designed to address the evolving needs of the extracellular vesicle field.

We work in close collaboration with academic institutions, biotechnology companies, research organizations, and clinical programs, serving as a trusted scientific and technological partner throughout the EV research and development journey.

Our Mission

At BioVexLab Solutions, our mission is to advance extracellular vesicle science through rigorous, innovative, and reliable technologies.

We provide specialized solutions for the isolation, characterization, and biological evaluation of nanoscale vesicles across diverse biological systems. Our approach is built on scientific rigor, technological excellence, and a commitment to reproducibility, enabling our partners to better understand EV biology and unlock their potential for biomedical and biotechnological applications.

By integrating complementary technologies and multidisciplinary expertise, we aim to accelerate the transition from scientific discovery to innovation.

Our Expertise

Comprehensive EV Characterization Through Complementary Technologies

Understanding extracellular vesicles requires more than a single analytical measurement. At BioVexLab Solutions, we combine complementary technologies and scientific expertise to provide a comprehensive view of EV populations and their key characteristics.

Our analytical capabilities include:

• Nanoparticle Tracking Analysis (NTA) - for particle concentration and size distribution
• NanoFCM - for high-resolution analysis of nanoscale particles and EV populations
• Zeta Potential Analysis - for evaluating surface charge and physicochemical properties
• Transmission Electron Microscopy (TEM) - for morphological assessment and structural visualization
• Fluorescence-Based EV Detection -for the detection and characterization of specific vesicle populations
• Protein and Biomarker Profiling - for molecular characterization and biological investigation

By integrating multiple complementary analytical approaches, we help reduce method-specific bias and provide a more comprehensive understanding of extracellular vesicle populations.

Our technology-driven approach supports robust characterization, reliable data generation, and informed decision-making across the EV research and development pipeline.

Advancing the Potential of Extracellular Vesicles

Extracellular vesicles represent a rapidly evolving field with significant potential across biomedical research, diagnostics, therapeutics, drug delivery, and biotechnology.

At BioVexLab Solutions, we are committed to contributing to this emerging ecosystem by providing the scientific expertise, technological capabilities, and collaborative approach required to move EV innovation forward.

Our Founders

BioVexLab Solutions was founded by Prof. Charles Ramassamy and Dr. Mohamed Haddad, two scientists with complementary expertise and a shared commitment to advancing extracellular vesicle research and innovation.

Prof. Charles Ramassamy, Co-Founder, Scientific & Strategic Director, is an experienced biomedical researcher with extensive expertise in molecular mechanisms, neurodegenerative diseases, biomarkers, and translational research. His scientific leadership and multidisciplinary research background contribute to the development of innovative strategies for understanding complex biological systems and advancing extracellular vesicle research toward clinically relevant applications.

Dr. Mohamed Haddad, Co-Founder, Scientific Innovation & Technology Leader, specializes in extracellular vesicle technologies, including EV isolation, purification, characterization, and analytical methodologies. His expertise spans multiple EV sources and advanced analytical platforms, with a particular focus on developing robust workflows and innovative approaches that support the translation of EV research into practical biomedical and biotechnological applications.

Together, the founders bring together complementary strengths in biomedical science, extracellular vesicle technology, analytical characterization, and translational innovation.

Their shared vision is to establish BioVexLab Solutions as a trusted partner for researchers and innovators seeking to advance extracellular vesicle science, from fundamental discovery and analytical characterization to the development of next-generation EV-based technologies and applications.

From scientific discovery to real world-impact, we transform extracellular vesicle science into innovative solutions and next-generation biomedical applications